However, for bladder cancer (BLCA), cervical squamous cell carcinoma (CESC), kidney renal clear cell carcinoma (KIRC), and uterine corpus endometrial carcinoma (UCEC), the expression of BRD4 in tissues from patients was not significantly higher than that in tissues from healthy subjects (Fig. 1a). This evidence concerns the gene BRD4 and urinary bladder cancer.